Page 93 - HIVMED_v21_i1.indb

Page 2 of 34 Guideline

2.5.1 HIV testing and counselling ............................................................................16
2.5.2 Antiretroviral therapy .....................................................................................16

2.5.3 Prevention of mother-to-child transmission of HIV .......................................16
2.6 Prevention and management of coinfections and comorbidities ...............................17
2.6.1 Tuberculosis services ......................................................................................17

2.6.2 Viral hepatitis services ....................................................................................17
2.6.3 Mental health services ...................................................................................18
2.6.4 Sexual and reproductive health services ........................................................18
2.7 Critical enablers ..........................................................................................................18
2.7.1 Supportive law and policy ..............................................................................18

2.7.2 Countering stigma and discrimination ...........................................................18
2.7.3 Enabling community empowerment ..............................................................19
2.7.4 Acting against violence ...................................................................................19

3. Special considerations .........................................................................................................19
3.1 Young people who use drugs ......................................................................................35
3.2 Women who use drugs ...............................................................................................20
3.3 Substance use in the context of sexual encounters ....................................................21
3.4 Prison settings ............................................................................................................21

4. Recommendations...............................................................................................................22
5. Acknowledgements .............................................................................................................23
Glossary ..............................................................................................................................24

References .........................................................................................................................25
Appendix 1: Common myths about drugs use ...........................................................................28
Appendix 2: Assessing patients during first and subsequent encounters ..................................29
Appendix 3: Guidelines for opioid substitution therapy .............................................................30
Appendix 4: Psychosocial and mental health interventions .......................................................34

http://www.sajhivmed.org.za 85 Open Access